These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26489828)

  • 1. New Compound Classes: Protein-Protein Interactions.
    Ottmann C
    Handb Exp Pharmacol; 2016; 232():125-38. PubMed ID: 26489828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of protein-protein interactions in drug discovery.
    Andrei SA; Sijbesma E; Hann M; Davis J; O'Mahony G; Perry MWD; Karawajczyk A; Eickhoff J; Brunsveld L; Doveston RG; Milroy LG; Ottmann C
    Expert Opin Drug Discov; 2017 Sep; 12(9):925-940. PubMed ID: 28695752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of Protein-Protein Interactions in chemical biology and drug discovery.
    Bier D; Thiel P; Briels J; Ottmann C
    Prog Biophys Mol Biol; 2015 Oct; 119(1):10-9. PubMed ID: 26093250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
    Thiel P; Kaiser M; Ottmann C
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of protein-protein interactions by small molecules.
    Giordanetto F; Schäfer A; Ottmann C
    Drug Discov Today; 2014 Nov; 19(11):1812-1821. PubMed ID: 25173701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-protein interactions as drug targets.
    Skwarczynska M; Ottmann C
    Future Med Chem; 2015; 7(16):2195-219. PubMed ID: 26510391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization and inhibition of protein-protein interactions: the 14-3-3 case study.
    Milroy LG; Brunsveld L; Ottmann C
    ACS Chem Biol; 2013 Jan; 8(1):27-35. PubMed ID: 23210482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of Rigidity in Designing Small Molecule Drugs To Tackle Protein-Protein Interactions (PPIs) through Stabilization of Desired Conformers.
    Lawson ADG; MacCoss M; Heer JP
    J Med Chem; 2018 May; 61(10):4283-4289. PubMed ID: 29140691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative modulation of protein-protein interactions by small molecules.
    Fischer G; Rossmann M; Hyvönen M
    Curr Opin Biotechnol; 2015 Dec; 35():78-85. PubMed ID: 25935873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulators of 14-3-3 Protein-Protein Interactions.
    Stevers LM; Sijbesma E; Botta M; MacKintosh C; Obsil T; Landrieu I; Cau Y; Wilson AJ; Karawajczyk A; Eickhoff J; Davis J; Hann M; O'Mahony G; Doveston RG; Brunsveld L; Ottmann C
    J Med Chem; 2018 May; 61(9):3755-3778. PubMed ID: 28968506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-Protein Interaction Inhibition (2P2I)-Oriented Chemical Library Accelerates Hit Discovery.
    Milhas S; Raux B; Betzi S; Derviaux C; Roche P; Restouin A; Basse MJ; Rebuffet E; Lugari A; Badol M; Kashyap R; Lissitzky JC; Eydoux C; Hamon V; Gourdel ME; Combes S; Zimmermann P; Aurrand-Lions M; Roux T; Rogers C; Müller S; Knapp S; Trinquet E; Collette Y; Guillemot JC; Morelli X
    ACS Chem Biol; 2016 Aug; 11(8):2140-8. PubMed ID: 27219844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecules, big targets: drug discovery faces the protein-protein interaction challenge.
    Scott DE; Bayly AR; Abell C; Skidmore J
    Nat Rev Drug Discov; 2016 Aug; 15(8):533-50. PubMed ID: 27050677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule protein-protein interaction inhibitors: therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations.
    Buchwald P
    IUBMB Life; 2010 Oct; 62(10):724-31. PubMed ID: 20979208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-Molecule Stabilization of the 14-3-3/Gab2 Protein-Protein Interaction (PPI) Interface.
    Bier D; Bartel M; Sies K; Halbach S; Higuchi Y; Haranosono Y; Brummer T; Kato N; Ottmann C
    ChemMedChem; 2016 Apr; 11(8):911-8. PubMed ID: 26644359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hot spot-based design of small-molecule inhibitors for protein-protein interactions.
    Guo W; Wisniewski JA; Ji H
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2546-54. PubMed ID: 24751445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focused chemical libraries--design and enrichment: an example of protein-protein interaction chemical space.
    Zhang X; Betzi S; Morelli X; Roche P
    Future Med Chem; 2014 Jul; 6(11):1291-307. PubMed ID: 24773599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in discovery of small-molecule modulators of protein-protein interactions via fragment screening.
    Magee TV
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2461-8. PubMed ID: 25971770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays.
    Gul S; Hadian K
    Expert Opin Drug Discov; 2014 Dec; 9(12):1393-404. PubMed ID: 25374163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area.
    Ran X; Gestwicki JE
    Curr Opin Chem Biol; 2018 Jun; 44():75-86. PubMed ID: 29908451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the relationship between hub proteins and drug targets based on GO and intrinsic disorder.
    Fu Y; Guo Y; Wang Y; Luo J; Pu X; Li M; Zhang Z
    Comput Biol Chem; 2015 Jun; 56():41-8. PubMed ID: 25854804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.